Community-acquired lung abscess caused by Legionella micdadei in a myeloma patient receiving thalidomide treatment.
Legionella infection causes 2 to 14% of community-acquired pneumonia (CAP). Legionella micdadei constitutes <1% of these infections. We describe a case of cavitary L. micdadei CAP in a myeloma patient receiving thalidomide treatment. The importance of considering pneumonia and problems in diagnosing pneumonia caused by L. micdadei in this patient population are reviewed.
Girard
Louis P
LP
Division of Medicine, University of Calgary, 9-3535 Research Road NW, Calgary, Alberta, Canada T2L 2K8.
Gregson
Daniel B
DB
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007875:Legionella / Q000302:isolation & purification*; D007876:Legionellosis / Q000188:drug therapy / Q000382:microbiology*; D008169:Lung Abscess / Q000188:drug therapy / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D013792:Thalidomide / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D013792:Thalidomide; D017963:Azithromycin